© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 16, 1308-1316,
August 16, 2000
© 2000 Oxford University Press
Lung Cancer Mortality in the Mayo Lung Project: Impact of Extended Follow-up
Affiliations of authors: P. M. Marcus, R. M. Fagerstrom, P. C. Prorok, Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD; E. J. Bergstralh, W. F. Taylor (Biostatistics Section), D. E. Williams, R. Fontana (Division of Pulmonary and Critical Care Medicine), Mayo Clinic, Rochester, MN.
Correspondence to: Pamela M. Marcus, Ph.D., M.S., National Institutes of Health, 6130 Executive Blvd., MSC 7354, Suite 344, Bethesda, MD 20892-7354 (e-mail: pm145q{at}nih.gov).
Background: The Mayo Lung Project (MLP) was a randomized, controlled clinical trial of lung cancer screening that was conducted in 9211 male smokers between 1971 and 1983. The intervention arm was offered chest x-ray and sputum cytology every 4 months for 6 years; the usual-care arm was advised at trial entry to receive the same tests annually. No lung cancer mortality benefit was evident at the end of the study. We have extended follow-up through 1996. Methods: A National Death Index–PLUS search was used to assign vital status and date and cause of death for 6523 participants with unknown information. The median survival for lung cancer patients diagnosed before July 1, 1983, was calculated by use of Kaplan–Meier estimates. Survival curves were compared with the log-rank test. Results: The median follow-up time was 20.5 years. Lung cancer mortality was 4.4 (95% confidence interval [CI] = 3.9–4.9) deaths per 1000 person-years in the intervention arm and 3.9 (95% CI = 3.5–4.4) in the usual-care arm (two-sided P for difference = .09). For participants diagnosed with lung cancer before July 1, 1983, survival was better in the intervention arm (two-sided P = .0039). The median survival for patients with resected early-stage disease was 16.0 years in the intervention arm versus 5.0 years in the usual-care arm. Conclusions: Extended follow-up of MLP participants did not reveal a lung cancer mortality reduction for the intervention arm. Similar mortality but better survival for individuals in the intervention arm indicates that some lesions with limited clinical relevance may have been identified in the intervention arm.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. G. Welch and P. C. Albertsen Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986-2005 J Natl Cancer Inst, October 7, 2009; 101(19): 1325 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. W. Brawley Prostate Cancer Screening; Is This a Teachable Moment? J Natl Cancer Inst, October 7, 2009; 101(19): 1295 - 1297. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Infante, S. Cavuto, F. R. Lutman, G. Brambilla, G. Chiesa, G. Ceresoli, E. Passera, E. Angeli, M. Chiarenza, G. Aranzulla, et al. A Randomized Study of Lung Cancer Screening with Spiral Computed Tomography: Three-year Results from the DANTE Trial Am. J. Respir. Crit. Care Med., September 1, 2009; 180(5): 445 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A Silvestri, A. J Alberg, and J. Ravenel The changing epidemiology of lung cancer with a focus on screening BMJ, August 17, 2009; 339(aug17_1): b3053 - b3053. [Full Text]
|
|
|
|
 |
|
 D. P Slovut Screening renal angiography as a routine part of cardiac catheterization: a reappraisal Vascular Medicine, August 1, 2009; 14(3): 271 - 275. [PDF]
|
|
|
|
 |
|
 R Ghosal, P Kloer, and K E Lewis A review of novel biological tools used in screening for the early detection of lung cancer Postgrad. Med. J., July 1, 2009; 85(1005): 358 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-G. Fan, P. Hu, Y. Jiang, R.-S. Chang, S.-X. Yao, W. Wang, J. He, P. Prorok, and Y.-L. Qiao Association Between Sputum Atypia and Lung Cancer Risk in an Occupational Cohort in Yunnan, China Chest, March 1, 2009; 135(3): 778 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. E. Miller Minimizing Unintended Consequences of Detecting Lung Nodules by Computed Tomography Am. J. Respir. Crit. Care Med., November 1, 2008; 178(9): 891 - 892. [Full Text] [PDF]
|
|
|
|
 |
|
 S. G Baker, B. S Kramer, and P. C Prorok Early reporting for cancer screening trials J Med Screen, September 1, 2008; 15(3): 122 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. McMahon, C. Y. Kong, B. E. Johnson, M. C. Weinstein, J. C. Weeks, K. M. Kuntz, J.-A. O. Shepard, S. J. Swensen, and G. S. Gazelle Estimating Long-term Effectiveness of Lung Cancer Screening in the Mayo CT Screening Study Radiology, July 1, 2008; 248(1): 278 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J M Reich A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening Thorax, April 1, 2008; 63(4): 377 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G A Silvestri and S G Spiro Carcinoma of the bronchus 60 years later Postgrad. Med. J., April 1, 2008; 84(990): 182 - 187. [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Ravenel, P. Costello, and G. A. Silvestri Screening for Lung Cancer Am. J. Roentgenol., March 1, 2008; 190(3): 755 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Byers, H. J. Wolf, W. A. Franklin, S. Braudrick, D. T. Merrick, K. R. Shroyer, F. R. Hirsch, C. Zeng, A. E. Baron, P. A. Bunn, et al. Sputum Cytologic Atypia Predicts Incident Lung Cancer: Defining Latency and Histologic Specificity Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 158 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. F. Patz Jr, M. J. Campa, E. B. Gottlin, I. Kusmartseva, X. R. Guan, and J. E. Herndon II Panel of Serum Biomarkers for the Diagnosis of Lung Cancer J. Clin. Oncol., December 10, 2007; 25(35): 5578 - 5583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. G. Welch, S. Woloshin, L. M. Schwartz, L. Gordis, P. C. Gotzsche, R. Harris, B. S. Kramer, and D. F. Ransohoff Overstating the Evidence for Lung Cancer Screening: The International Early Lung Cancer Action Program (I-ELCAP) Study Arch Intern Med, November 26, 2007; 167(21): 2289 - 2295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Bach, G. A. Silvestri, M. Hanger, and J. R. Jett Screening for Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 69S - 77S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Loewen, N. Natarajan, D. Tan, E. Nava, D. Klippenstein, M. Mahoney, M. Cummings, and M. Reid Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment Thorax, April 1, 2007; 62(4): 335 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. B. Bach, J. R. Jett, U. Pastorino, M. S. Tockman, S. J. Swensen, and C. B. Begg Computed Tomography Screening and Lung Cancer Outcomes JAMA, March 7, 2007; 297(9): 953 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G Spiro Screening for lung cancer: yet another problem Thorax, February 1, 2007; 62(2): 105 - 106. [Full Text] [PDF]
|
|
|
|
|
|
R. M. Lindell, T. E. Hartman, S. J. Swensen, J. R. Jett, D. E. Midthun, H. D. Tazelaar, and J. N. Mandrekar Five-year Lung Cancer Screening Experience: CT Appearance, Growth Rate, Location, and Histologic Features of 61 Lung Cancers Radiology, February 1, 2007; 242(2): 555 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A Silvestri, P. J Nietert, J. Zoller, C. Carter, and D. Bradford Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts Thorax, February 1, 2007; 62(2): 126 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Knudsen, P. M. McMahon, and G. S. Gazelle Use of Modeling to Evaluate the Cost-Effectiveness of Cancer Screening Programs J. Clin. Oncol., January 10, 2007; 25(2): 203 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Silvestri Screening for lung cancer in a high-risk group: but I still haven't found what I'm looking for... Eur. Respir. J., January 1, 2007; 29(1): 6 - 7. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Schoder and M. Gonen Screening for Cancer with PET and PET/CT: Potential and Limitations J. Nucl. Med., January 1, 2007; 48(1_suppl): 4S - 18S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G A Silvestri and S G Spiro Carcinoma of the bronchus 60 years later. Thorax, December 1, 2006; 61(12): 1023 - 1028. [Full Text] [PDF]
|
|
|
|
|
|
P. M. Marcus, E. J. Bergstralh, M. H. Zweig, A. Harris, K. P. Offord, and R. S. Fontana Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst, June 7, 2006; 98(11): 748 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. T. Bolliger, T. G. Sutedja, J. Strausz, and L. Freitag Therapeutic bronchoscopy with immediate effect: laser, electrocautery, argon plasma coagulation and stents. Eur. Respir. J., June 1, 2006; 27(6): 1258 - 1271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Reich Assessing the Efficacy of Lung Cancer Screening Radiology, February 1, 2006; 238(2): 398 - 401. [Full Text] [PDF]
|
|
|
|
|
|
F V Gleeson Is screening for lung cancer using low dose spiral CT scanning worthwhile? Thorax, January 1, 2006; 61(1): 5 - 7. [Full Text] [PDF]
|
|
|
|
|
|
M. M. Oken, P. M. Marcus, P. Hu, T. M. Beck, W. Hocking, P. A. Kvale, J. Cordes, T. L. Riley, S. D. Winslow, S. Peace, et al. Baseline Chest Radiograph for Lung Cancer Detection in the Randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial J Natl Cancer Inst, December 21, 2005; 97(24): 1832 - 1839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Spiro and G. A. Silvestri One Hundred Years of Lung Cancer Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 523 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Jett Limitations of Screening for Lung Cancer with Low-Dose Spiral Computed Tomography Clin. Cancer Res., July 1, 2005; 11(13): 4988s - 4992s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Mulshine Clinical Issues in the Management of Early Lung Cancer Clin. Cancer Res., July 1, 2005; 11(13): 4993s - 4998s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Strauss, L. Dominioni, J. R. Jett, M. Freedman, and F. W. Grannis Jr Como International Conference Position Statement: Lung Cancer Screening for Early Diagnosis 5 Years After The 1998 Varese Conference Chest, April 1, 2005; 127(4): 1146 - 1151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Swensen, J. R. Jett, T. E. Hartman, D. E. Midthun, S. J. Mandrekar, S. L. Hillman, A.-M. Sykes, G. L. Aughenbaugh, A. O. Bungum, and K. L. Allen CT Screening for Lung Cancer: Five-year Prospective Experience Radiology, April 1, 2005; 235(1): 259 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Fujiwara, N. Fujimoto, M. Tabata, K. Nishii, K. Matsuo, K. Hotta, T. Kozuki, M. Aoe, K. Kiura, H. Ueoka, et al. Identification of Epigenetic Aberrant Promoter Methylation in Serum DNA Is Useful for Early Detection of Lung Cancer Clin. Cancer Res., February 1, 2005; 11(3): 1219 - 1225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. W. Brawley and B. S. Kramer Cancer Screening in Theory and in Practice J. Clin. Oncol., January 10, 2005; 23(2): 293 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Stanley Screening Revisited Am. J. Roentgenol., December 1, 2004; 183(6): 1537 - 1537. [Full Text] [PDF]
|
|
|
|
|
|
S. Tigges, D. L. Roberts, K. H. Vydareny, and D. A. Schulman Routine Chest Radiography in a Primary Care Setting Radiology, November 1, 2004; 233(2): 575 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Meyer, R. T. Shipley, K. S. Lee, T. Johkoh, and R. Kakinuma Invited Commentary * Authors' Response RadioGraphics, November 1, 2004; 24(6): 1632 - 1636. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Calonge and J. D. Allan Screening for Lung Cancer Ann Intern Med, October 19, 2004; 141(8): 650 - 650. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Whitsett, C. J. Bachurski, K. C. Barnes, P. A. Bunn Jr., L. M. Case, D. N. Cook, D. Crooks, M. W. Duncan, L. Dwyer-Nield, R. C. Elston, et al. Functional Genomics of Lung Disease Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2/S1): S1 - S81. [Full Text] [PDF]
|
|
|
|
|
|
M. Sato, Y. Saito, C. Endo, A. Sakurada, D. Feller-Kopman, A. Ernst, and T. Kondo The Natural History of Radiographically Occult Bronchogenic Squamous Cell Carcinoma: A Retrospective Study of Overdiagnosis Bias Chest, July 1, 2004; 126(1): 108 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. F. Patz Jr, S. J. Swensen, and J. E. Herndon II Estimate of Lung Cancer Mortality From Low-Dose Spiral Computed Tomography Screening Trials: Implications for Current Mass Screening Recommendations J. Clin. Oncol., June 1, 2004; 22(11): 2202 - 2206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Humphrey, S. Teutsch, and M. Johnson Lung Cancer Screening with Sputum Cytologic Examination, Chest Radiography, and Computed Tomography: An Update for the U.S. Preventive Services Task Force Ann Intern Med, May 4, 2004; 140(9): 740 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Levy, S. Kunkel, K. Remmes, and M. Slade Wanted Dead or Alive: Implication of Death Classification on Longevity Research on Aging, May 1, 2004; 26(3): 317 - 329. [Abstract] [PDF]
|
|
|
|
|
|
I. Mecklenburg, D. F. Stratakis, R. M. Huber, K. Haussinger, A. Morresi-Hauf, G. Riethmuller, and P. Kufer Detection of Melanoma Antigen-A Expression in Sputum and Bronchial Lavage Fluid of Patients With Lung Cancer Chest, May 1, 2004; 125(5_suppl): 164S - 166S. [Full Text] [PDF]
|
|
|
|
|
|
M. Means-Markwell, R. I. Linnoila, J. Williams, P. A. Janne, F. Kaye, K. O'Neil, and B. E. Johnson Prospective Study of the Airways and Pulmonary Parenchyma of Patients at Risk for a Second Lung Cancer Clin. Cancer Res., December 1, 2003; 9(16): 5915 - 5921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Fenton and R. A. Deyo Patient Self-Referral for Radiologic Screening Tests: Clinical and Ethical Concerns J Am Board Fam Med, November 1, 2003; 16(6): 494 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Bunn Jr Early Detection of Lung Cancer Using Serum RNA or DNA Markers: Ready for """Prime Time""" or for Validation? J. Clin. Oncol., November 1, 2003; 21(21): 3891 - 3893. [Full Text] [PDF]
|
|
|
|
|
|
S. A. Prindiville, T. Byers, F. R. Hirsch, W. A. Franklin, Y. E. Miller, K. O. Vu, H. J. Wolf, A. E. Baron, K. R. Shroyer, C. Zeng, et al. Sputum Cytological Atypia as a Predictor of Incident Lung Cancer in a Cohort of Heavy Smokers with Airflow Obstruction Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 987 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R L Manser, L B Irving, G Byrnes, M J Abramson, C A Stone, and D A Campbell Screening for lung cancer: a systematic review and meta-analysis of controlled trials Thorax, September 1, 2003; 58(9): 784 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E Eberly, J. Ockene, R. Sherwin, L. Yang, and L. Kuller Pulmonary function as a predictor of lung cancer mortality in continuing cigarette smokers and in quitters Int. J. Epidemiol., August 1, 2003; 32(4): 592 - 599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Weiss Adjusting for Screening History in Epidemiologic Studies of Cancer: Why, When, and How to Do It Am. J. Epidemiol., June 1, 2003; 157(11): 957 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Earnest, S. J. Swensen, and F. E. Zink Respecting Patient Autonomy: Screening at CT and Informed Consent Radiology, March 1, 2003; 226(3): 633 - 634. [Full Text] [PDF]
|
|
|
|
|
|
S. J. Swensen, J. R. Jett, T. E. Hartman, D. E. Midthun, J. A. Sloan, A.-M. Sykes, G. L. Aughenbaugh, and M. A. Clemens Lung Cancer Screening with CT: Mayo Clinic Experience Radiology, March 1, 2003; 226(3): 756 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y Hakoda, Y Ito, A Nagate, K Minemura, K Utsumi, M Aoshima, and K Ohyashiki Increased collagenase activity in macrophages from bronchial lavage as a diagnostic marker of non-small cell lung cancer Thorax, February 1, 2003; 58(2): 122 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Quarterman, A. McMillan, M. B. Ratcliffe, and M. I. Block Effect of preoperative delay on prognosis for patients with early stage non-small cell lung cancer J. Thorac. Cardiovasc. Surg., January 1, 2003; 125(1): 108 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Boyle Screening Eur. Respir. J., January 1, 2003; 21(39_suppl): 3S - 15s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Sutedja New techniques for early detection of lung cancer Eur. Respir. J., January 1, 2003; 21(39_suppl): 57S - 66s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Bach, M. J. Kelley, R. C. Tate, and D. C. McCrory Screening for Lung Cancer: A Review of the Current Literature Chest, January 1, 2003; 123 (2009): 72S - 82S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Swensen CT Screening for Lung Cancer Am. J. Roentgenol., October 1, 2002; 179(4): 833 - 836. [Full Text] [PDF]
|
|
|
|
|
|
P. M. Marcus Lung Cancer Screening, Once Again Chest, July 1, 2002; 122(1): 3 - 4. [Full Text] [PDF]
|
|
|
|
|
|
J. M. Reich Improved Survival and Higher Mortality* : The Conundrum of Lung Cancer Screening Chest, July 1, 2002; 122(1): 329 - 337. [Full Text] [PDF]
|
|
|
|
|
|
J. R. Jett Screening for Lung Cancer: No Longer a Taboo Subject J. Clin. Oncol., April 15, 2002; 20(8): 1959 - 1961. [Full Text] [PDF]
|
|
|
|
|
|
G. M. Strauss The Mayo Lung Cohort: A Regression Analysis Focusing on Lung Cancer Incidence and Mortality J. Clin. Oncol., April 15, 2002; 20(8): 1973 - 1983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. SWENSEN, J. R. JETT, J. A. SLOAN, D. E. MIDTHUN, T. E. HARTMAN, A.-M. SYKES, G. L. AUGHENBAUGH, F. E. ZINK, S. L. HILLMAN, G. R. NOETZEL, et al. Screening for Lung Cancer with Low-Dose Spiral Computed Tomography Am. J. Respir. Crit. Care Med., February 15, 2002; 165(4): 508 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Lee and T. A. Brennan Direct-to-Consumer Marketing of High-Technology Screening Tests N. Engl. J. Med., February 14, 2002; 346(7): 529 - 531. [Full Text] [PDF]
|
|
|
|
|
|
W. C. Black, D. A. Haggstrom, and H. Gilbert Welch All-Cause Mortality in Randomized Trials of Cancer Screening J Natl Cancer Inst, February 6, 2002; 94(3): 167 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kodama, M. Higashiyama, H. Yokouchi, K. Takami, K. Kuriyama, Y. Kusunoki, T. Nakayama, and F. Imamura Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years Ann. Thorac. Surg., February 1, 2002; 73(2): 386 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. F. Patz Jr, W. C. Black, and P. C. Goodman Commentary on Drs Miettinen and Henschke's Viewpoint Radiology, December 1, 2001; 221(3): 597 - 597. [Full Text] [PDF]
|
|
|
|
|
|
R.J. van Klaveren, J.D.F. Habbema, J.H. Pedersen, H.J. de Koning, M. Oudkerk, and H.C. Hoogsteden Lung cancer screening by low-dose spiral computed tomography Eur. Respir. J., November 1, 2001; 18(5): 857 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Stanley Inherent Dangers in Radiologic Screening Am. J. Roentgenol., November 1, 2001; 177(5): 989 - 992. [Full Text] [PDF]
|
|
|
|
|
|
P. M. Marcus Lung Cancer Screening: An Update J. Clin. Oncol., September 15, 2001; 19(90001): 83s - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Kennedy, S. Lam, and F. R. Hirsch Review of Recent Advances in Fluorescence Bronchoscopy in Early Localization of Central Airway Lung Cancer Oncologist, June 1, 2001; 6(3): 257 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Ganz and M. S. Litwin Prostate Cancer: The Price of Early Detection J. Clin. Oncol., March 15, 2001; 19(6): 1587 - 1588. [Full Text] [PDF]
|
|
|
|
|
|
E. F. Patz Jr. and P. C. Goodman Low-Dose Spiral Computed Tomography Screening For Lung Cancer: Not Ready for Prime Time Am. J. Respir. Crit. Care Med., March 15, 2001; 163(4): 813 - 814. [Full Text]
|
|
|
|
|
|
T. Sobue and T. Nakayama Re: Lung Cancer Mortality in the Mayo Lung Project: Impact of Extended Follow-up J Natl Cancer Inst, February 21, 2001; 93(4): 320 - 321. [Full Text] [PDF]
|
|
|
|
|
|
R. A. Badwe Re: Lung Cancer Mortality in the Mayo Lung Project: Impact of Extended Follow-up J Natl Cancer Inst, February 21, 2001; 93(4): 321 - 321. [Full Text] [PDF]
|
|
|
|
|
|
P. M. Marcus, R. M. Fagerstrom, and P. C. Prorok RESPONSE: Re: Lung Cancer Mortality in the Mayo Lung Project: Impact of Extended Follow-up J Natl Cancer Inst, February 21, 2001; 93(4): 322 - 322. [Full Text] [PDF]
|
|
|
|
|
|
F. W. Grannis Jr. Lung Cancer Overdiagnosis Bias : "The Gyanousa Am Loose!" Chest, February 1, 2001; 119(2): 322 - 323. [Full Text] [PDF]
|
|
|
|
|
|
F. R. Hirsch, W. A. Franklin, A. F. Gazdar, and P. A. Bunn Jr. Early Detection of Lung Cancer: Clinical Perspectives of Recent Advances in Biology and Radiology Clin. Cancer Res., January 1, 2001; 7(1): 5 - 22. [Abstract] [Full Text]
|
|
|
|
 |
|
 More Follow-Up from a Lung Cancer Screening Trial Journal Watch (General), September 12, 2000; 2000(912): 2 - 2. [Full Text]
|
|
|
|
|
|
W. C. Black Overdiagnosis: An Underrecognized Cause of Confusion and Harm in Cancer Screening J Natl Cancer Inst, August 16, 2000; 92(16): 1280 - 1282. [Full Text] [PDF]
|
|
|
|
|
|
E. F. Patz Jr, W. C. Black, and P. C. Goodman CT Screening for Lung Cancer: Not Ready for Routine Practice Radiology, December 1, 2001; 221(3): 587 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. S. Miettinen and C. I. Henschke CT Screening for Lung Cancer: Coping with Nihilistic Recommendations Radiology, December 1, 2001; 221(3): 592 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Diederich, D. Wormanns, M. Semik, M. Thomas, H. Lenzen, N. Roos, and W. Heindel Screening for Early Lung Cancer with Low-Dose Spiral CT: Prevalence in 817 Asymptomatic Smokers Radiology, March 1, 2002; 222(3): 773 - 781. [Abstract] [Full Text] [PDF]
|
|